JP Morgan Chase
HCAT icon

JP Morgan Chase’s Health Catalyst HCAT Stock Holding History

JP Morgan Chase’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-45,900
Closed -$445K – 6736
2022
Q3 		$445K Buy
+45,900
New +$608K ﹤0.01% 4534

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's HCAT Position: Q2 2026 in Review

JP Morgan Chase reduced its Health Catalyst (HCAT) stake by 100% in Q2 2026, selling an estimated $976K and leaving 1,947 shares worth $3.82K. The position accounts for ﹤0.01% of the portfolio, ranked #7120.

JP Morgan Chase first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $26.3M in Q2 2023. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • JP Morgan Chase held 1,947 shares of Health Catalyst worth $3.82K as of Q2 2026.
  • JP Morgan Chase sold 676,002 Health Catalyst shares in Q2 2026, an estimated $976K.
  • Health Catalyst made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7120 holding.
  • JP Morgan Chase first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • JP Morgan Chase's Health Catalyst position peaked at $26.3M in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.